Table: SymBio Pharmaceuticals -2022 group results

SymBio Pharmaceuticals

09/02/2023 06:30

Feb 9 (Reuters)- 
          SymBio Pharmaceuticals Limited 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to        NEXT   
                Dec 31, 2022    Dec 31, 2021    Dec 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY       COMPANY   
                   RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales             10.01                           7.00                  
                                                (-30.1 pct)               
  Operating          1.96                       loss 331 mln              
  Recurring          2.00                       loss 351 mln              
  Net
  Net                1.18                       loss 370 mln              
  EPS             30.20 yen                    loss 9.48 yen              
  EPS Diluted     29.77 yen                                               
  Ann Div            NIL             NIL            NIL                   
  -Q2 Div            NIL             NIL            NIL                   
  -Q4 Div            NIL             NIL            NIL                   
  
  NOTE - SymBio Pharmaceuticals Limited.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T